Liquid Biopsy: The Unique Test for Chasing the Genetics of Solid Tumors

Author:

Aghamir Seyed Mohammad Kazem1,Heshmat Ramin2,Ebrahimi Mehdi3,Khatami Fatemeh1ORCID

Affiliation:

1. Urology Research Center (URC), Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

2. Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

3. Department of Internal Medicine, Faculty of Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran Iran

Abstract

Blood test is a kind of liquid biopsy that checks cancer cells or cancer nucleic acids circulating freely from cells in the blood. A liquid biopsy may be used to distinguish cancer at early stages and it could be a game-changer for both cancer diagnosis and prognosis strategies. Liquid biopsy tests consider several tumor components, such as DNA, RNA, proteins, and the tiny vesicles originating from tumor cells. Actually, liquid biopsy signifies the genetic alterations of tumors through nucleic acids or cells in various body fluids, including blood, urine, cerebrospinal fluid, or saliva in a noninvasive manner. In this review, we present an overall description of liquid biopsy in which circulating tumor cells, cell-free nucleic acids, exosomes, and extrachromosomal circular DNA are included.

Publisher

SAGE Publications

Subject

Genetics,Biochemistry

Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Molecular biology and genetic change definition;Genetics and Epigenetics of Genitourinary Diseases;2025

2. Molecular biology and epigenetic modifications definition;Genetics and Epigenetics of Genitourinary Diseases;2025

3. Molecular biology, genetic, and epigenetics of kidney tumor;Genetics and Epigenetics of Genitourinary Diseases;2025

4. The role of methylation quantification of circulating tumor DNA (ctDNA) as a diagnostic biomarker of Pheochromocytomas (PCCs) and Paragangliomas (PGLs);Journal of Diabetes & Metabolic Disorders;2024-07-20

5. Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers;Urologic Clinics of North America;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3